 Immunoblotting
"Immunoblotting" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Immunologic method used for detecting or quantifying immunoreactive substances. The substance is identified by first immobilizing it by blotting onto a membrane and then tagging it with labeled antibodies.
| Descriptor ID |
D015151
|
| MeSH Number(s) |
E05.478.566.320 E05.601.495.320
|
| Concept/Terms |
Immunoblotting, Reverse- Immunoblotting, Reverse
- Immunoblottings, Reverse
- Reverse Immunoblottings
- Reverse Immunoblotting
Immunoelectroblotting- Immunoelectroblotting
- Immunoelectroblottings
- Electroimmunoblotting
- Electroimmunoblottings
Dot Immunoblotting- Dot Immunoblotting
- Immunoblotting, Dot
- Dot Immunoblottings
- Immunoblottings, Dot
|
Below are MeSH descriptors whose meaning is more general than "Immunoblotting".
Below are MeSH descriptors whose meaning is more specific than "Immunoblotting".
This graph shows the total number of publications written about "Immunoblotting" by people in UAMS Profiles by year, and whether "Immunoblotting" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2021 | 0 | 2 | 2 | | 2020 | 0 | 1 | 1 | | 2017 | 0 | 4 | 4 | | 2016 | 0 | 2 | 2 | | 2015 | 0 | 6 | 6 | | 2014 | 0 | 3 | 3 | | 2013 | 0 | 4 | 4 | | 2012 | 0 | 1 | 1 | | 2011 | 0 | 5 | 5 | | 2010 | 0 | 8 | 8 | | 2009 | 0 | 8 | 8 | | 2008 | 0 | 3 | 3 | | 2007 | 0 | 1 | 1 | | 2006 | 0 | 4 | 4 | | 2005 | 0 | 4 | 4 | | 2004 | 0 | 3 | 3 | | 2003 | 0 | 4 | 4 | | 2002 | 0 | 2 | 2 | | 2000 | 0 | 4 | 4 | | 1999 | 0 | 3 | 3 | | 1998 | 0 | 1 | 1 | | 1997 | 0 | 2 | 2 | | 1996 | 0 | 2 | 2 | | 1995 | 0 | 6 | 6 | | 1993 | 0 | 1 | 1 | | 1992 | 0 | 1 | 1 | | 1990 | 0 | 3 | 3 | | 1989 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Immunoblotting" by people in Profiles over the past ten years.
-
Sridharan V, Johnson KA, Landes RD, Cao M, Singh P, Wagoner G, Hayar A, Sprick ED, Eveld KA, Bhattacharyya A, Krager KJ, Aykin-Burns N, Weiler H, Fern?ndez JA, Griffin JH, Boerma M. Sex-dependent effects of genetic upregulation of activated protein C on delayed effects of acute radiation exposure in the mouse heart, small intestine, and skin. PLoS One. 2021; 16(5):e0252142.
-
Kolb R, De U, Khan S, Luo Y, Kim MC, Yu H, Wu C, Mo J, Zhang X, Zhang P, Zhang X, Borcherding N, Koppel D, Fu YX, Zheng SG, Avram D, Zheng G, Zhou D, Zhang W. Proteolysis-targeting chimera against BCL-XL destroys tumor-infiltrating regulatory T cells. Nat Commun. 2021 02 24; 12(1):1281.
-
Lei MG, Lee CY. MgrA Activates Staphylococcal Capsule via SigA-Dependent Promoter. J Bacteriol. 2020 12 18; 203(2).
-
Zhu AS, Li A, Ratliff TS, Melsom M, Garza LA. After Skin Wounding, Noncoding dsRNA Coordinates Prostaglandins and Wnts to Promote Regeneration. J Invest Dermatol. 2017 07; 137(7):1562-1568.
-
Bawa-Khalfe T, Yang FM, Ritho J, Lin HK, Cheng J, Yeh ET. SENP1 regulates PTEN stability to dictate prostate cancer development. Oncotarget. 2017 Mar 14; 8(11):17651-17664.
-
Jin HY, Oda H, Chen P, Yang C, Zhou X, Kang SG, Valentine E, Kefauver JM, Liao L, Zhang Y, Gonzalez-Martin A, Shepherd J, Morgan GJ, Mondala TS, Head SR, Kim PH, Xiao N, Fu G, Liu WH, Han J, Williamson JR, Xiao C. Differential Sensitivity of Target Genes to Translational Repression by miR-17~92. PLoS Genet. 2017 02; 13(2):e1006623.
-
Bagu ET, Miah S, Dai C, Spriggs T, Ogunbolude Y, Beaton E, Sanders M, Goel RK, Bonham K, Lukong KE. Repression of Fyn-related kinase in breast cancer cells is associated with promoter site-specific CpG methylation. Oncotarget. 2017 Feb 14; 8(7):11442-11459.
-
Colonne PM, Winchell CG, Graham JG, Onyilagha FI, MacDonald LJ, Doeppler HR, Storz P, Kurten RC, Beare PA, Heinzen RA, Voth DE. Vasodilator-Stimulated Phosphoprotein Activity Is Required for Coxiella burnetii Growth in Human Macrophages. PLoS Pathog. 2016 Oct; 12(10):e1005915.
-
Ruebel M, Shankar K, Gaddy D, Lindsey F, Badger T, Andres A. Maternal obesity is associated with ovarian inflammation and upregulation of early growth response factor 1. Am J Physiol Endocrinol Metab. 2016 07 01; 311(1):E269-77.
-
Dai L, Trillo-Tinoco J, Cao Y, Bonstaff K, Doyle L, Del Valle L, Whitby D, Parsons C, Reiss K, Zabaleta J, Qin Z. Targeting HGF/c-MET induces cell cycle arrest, DNA damage, and apoptosis for primary effusion lymphoma. Blood. 2015 Dec 24; 126(26):2821-31.
-
Wager B, Shaw DK, Groshong AM, Blevins JS, Skare JT. BB0744 Affects Tissue Tropism and Spatial Distribution of Borrelia burgdorferi. Infect Immun. 2015 Sep; 83(9):3693-703.
-
Dai L, Cao Y, Chen Y, Kaleeba JA, Zabaleta J, Qin Z. Genomic analysis of xCT-mediated regulatory network: Identification of novel targets against AIDS-associated lymphoma. Oncotarget. 2015 May 20; 6(14):12710-22.
-
Fausther M, Goree JR, Lavoie ?G, Graham AL, S?vigny J, Dranoff JA. Establishment and characterization of rat portal myofibroblast cell lines. PLoS One. 2015; 10(3):e0121161.
-
Zhou J, Fujiwara T, Ye S, Li X, Zhao H. Ubiquitin E3 Ligase LNX2 is Critical for Osteoclastogenesis In Vitro by Regulating M-CSF/RANKL Signaling and Notch2. Calcif Tissue Int. 2015 May; 96(5):465-75.
-
Piemontese M, Onal M, Xiong J, Wang Y, Almeida M, Thostenson JD, Weinstein RS, Manolagas SC, O'Brien CA. Suppression of autophagy in osteocytes does not modify the adverse effects of glucocorticoids on cortical bone. Bone. 2015 Jun; 75:18-26.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|